Oliver A - Search Results

1

Risk factors for mortality among patients with Pseudomonas aeruginosa bacteraemia: a retrospective multicentre study.

Babich T, Naucler P, Valik JK, Giske CG, Benito N, Cardona R, Rivera A, Pulcini C, Fattah MA, Haquin J, MacGowan A, Grier S, Chazan B, Yanovskay A, Ami RB, Landes M, Nesher L, Zaidman-Shimshovitz A, McCarthy K, Paterson DL, Tacconelli E, Buhl M, Maurer S, Rodriguez-Bano J, Morales I, Oliver A, de Gopegui ER, Cano A, Machuca I, Gozalo-Marguello M, Martinez-Martinez L, Gonzalez-Barbera EM, Alfaro IG, Salavert M, Beovic B, Saje A, Mueller-Premru M, Pagani L, Vitrat V, Kofteridis D, Zacharioudaki M, Maraki S, Weissman Y, Paul M, Dickstein Y, Leibovici L, Yahav D. Babich T, et al. Among authors: oliver a. Int J Antimicrob Agents. 2020 Feb;55(2):105847. doi: 10.1016/j.ijantimicag.2019.11.004. Epub 2019 Nov 23. Int J Antimicrob Agents. 2020. PMID: 31770625

2

Hypermutation and the preexistence of antibiotic-resistant Pseudomonas aeruginosa mutants: implications for susceptibility testing and treatment of chronic infections.

Oliver A, Levin BR, Juan C, Baquero F, Blázquez J. Oliver A, et al. Antimicrob Agents Chemother. 2004 Nov;48(11):4226-33. doi: 10.1128/AAC.48.11.4226-4233.2004. Antimicrob Agents Chemother. 2004. PMID: 15504845 Free PMC article.

3

Hypermutation is a key factor in development of multiple-antimicrobial resistance in Pseudomonas aeruginosa strains causing chronic lung infections.

Maciá MD, Blanquer D, Togores B, Sauleda J, Pérez JL, Oliver A. Maciá MD, et al. Among authors: oliver a. Antimicrob Agents Chemother. 2005 Aug;49(8):3382-6. doi: 10.1128/AAC.49.8.3382-3386.2005. Antimicrob Agents Chemother. 2005. PMID: 16048951 Free PMC article.

4

Molecular mechanisms of beta-lactam resistance mediated by AmpC hyperproduction in Pseudomonas aeruginosa clinical strains.

Juan C, Maciá MD, Gutiérrez O, Vidal C, Pérez JL, Oliver A. Juan C, et al. Among authors: oliver a. Antimicrob Agents Chemother. 2005 Nov;49(11):4733-8. doi: 10.1128/AAC.49.11.4733-4738.2005. Antimicrob Agents Chemother. 2005. PMID: 16251318 Free PMC article.

5

Stepwise upregulation of the Pseudomonas aeruginosa chromosomal cephalosporinase conferring high-level beta-lactam resistance involves three AmpD homologues.

Juan C, Moyá B, Pérez JL, Oliver A. Juan C, et al. Among authors: oliver a. Antimicrob Agents Chemother. 2006 May;50(5):1780-7. doi: 10.1128/AAC.50.5.1780-1787.2006. Antimicrob Agents Chemother. 2006. PMID: 16641450 Free PMC article.

6

Benefit of having multiple ampD genes for acquiring beta-lactam resistance without losing fitness and virulence in Pseudomonas aeruginosa.

Moya B, Juan C, Albertí S, Pérez JL, Oliver A. Moya B, et al. Among authors: oliver a. Antimicrob Agents Chemother. 2008 Oct;52(10):3694-700. doi: 10.1128/AAC.00172-08. Epub 2008 Jul 21. Antimicrob Agents Chemother. 2008. PMID: 18644952 Free PMC article.

7

Characterization of the new metallo-beta-lactamase VIM-13 and its integron-borne gene from a Pseudomonas aeruginosa clinical isolate in Spain.

Juan C, Beceiro A, Gutiérrez O, Albertí S, Garau M, Pérez JL, Bou G, Oliver A. Juan C, et al. Among authors: oliver a. Antimicrob Agents Chemother. 2008 Oct;52(10):3589-96. doi: 10.1128/AAC.00465-08. Epub 2008 Jul 21. Antimicrob Agents Chemother. 2008. PMID: 18644957 Free PMC article.

8

Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.

Rodríguez-Baño J, Alcalá JC, Cisneros JM, Grill F, Oliver A, Horcajada JP, Tórtola T, Mirelis B, Navarro G, Cuenca M, Esteve M, Peña C, Llanos AC, Cantón R, Pascual A. Rodríguez-Baño J, et al. Among authors: oliver a. Arch Intern Med. 2008 Sep 22;168(17):1897-902. doi: 10.1001/archinte.168.17.1897. Arch Intern Med. 2008. PMID: 18809817

9

Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants.

Mulet X, Maciá MD, Mena A, Juan C, Pérez JL, Oliver A. Mulet X, et al. Among authors: oliver a. Antimicrob Agents Chemother. 2009 Apr;53(4):1552-60. doi: 10.1128/AAC.01264-08. Epub 2009 Feb 2. Antimicrob Agents Chemother. 2009. PMID: 19188376 Free PMC article.

10

Escherichia coli producing SHV-type extended-spectrum beta-lactamase is a significant cause of community-acquired infection.

Rodríguez-Baño J, Alcalá J, Cisneros JM, Grill F, Oliver A, Horcajada JP, Tórtola T, Mirelis B, Navarro G, Cuenca M, Esteve M, Peña C, Llanos AC, Cantón R, Pascual A. Rodríguez-Baño J, et al. Among authors: oliver a. J Antimicrob Chemother. 2009 Apr;63(4):781-4. doi: 10.1093/jac/dkp028. Epub 2009 Feb 17. J Antimicrob Chemother. 2009. PMID: 19223299

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,873 results

Search Page